HOMA-IR: difference between revisions
Diff·revision 19 → 20·22:18, 8 Sep 2025
Difference between revision 19 and revision 20 of HOMA-IR. 3 lines changed; the page grew by 293 bytes.
| Revision 19 — 08:59, 8 Aug 2025 DEXA_Dilys (talk) correct the analyte name to the recommended nomenclature 4,218 bytes ±0 | Revision 20 — 22:18, 8 Sep 2025 AAA_Analyst (talk) unpipe a link that did not need piping 4,511 bytes +293 | ||
|---|---|---|---|
| 42 | Under incretin therapy, both inputs move: insulin secretion is amplified while the drug is present, and sensitivity improves with weight loss. The resulting index change is therefore a composite, and attributing it to a change in sensitivity alone is unsound.{{r|wallace2004}} | 42 | Under incretin therapy, both inputs move: insulin secretion is amplified while the drug is present, and sensitivity improves with weight loss. The resulting index change is therefore a composite, and attributing it to a change in sensitivity alone is unsound.{{r|wallace2004}} |
| 43 | 43 | ||
| + | 44 | The index appears on many of the laboratory panels discussed in this field; see [[Baseline laboratory panel]]. Nothing on this wiki is medical advice.{{r|ada2024}} | |
| + | 45 | ||
| 44 | == References == | 46 | == References == |
| 45 | {{reflist}} | 47 | {{reflist}} |
| ⋮ | ⋮ | ||
| 47 | <ref name="wallace2004">Wallace TM, Levy JC, Matthews DR. "Use and abuse of HOMA modeling." ''Diabetes Care'' 27(6):1487–1495 (2004). PMID 15161807.</ref> | 49 | <ref name="wallace2004">Wallace TM, Levy JC, Matthews DR. "Use and abuse of HOMA modeling." ''Diabetes Care'' 27(6):1487–1495 (2004). PMID 15161807.</ref> |
| 48 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> | 50 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> |
| + | 51 | <ref name="ada2024">American Diabetes Association. "Standards of Care in Diabetes." ''Diabetes Care'' 47(Suppl 1) (2024).</ref> | |
| 49 | 52 | ||
| 50 | == See also == | 53 | == See also == |